2023-3453 - Continuous Glucose Monitoring

Newfoundland & Labrador Health Services (NLHS) is administering this tender to submit proposals for supply, education and support service for Continuous Glucose Monitoring (CGM). This will be in accordance with the specifications and requirements set out in this open call, as well as the Public Procurement Act.

The term of the agreement will be for a contract period of Two (2) years with an option to extend for an additional One (1) year.  
This Tender may be awarded to more than one supplier. Supplier selection shall be based on clinical assessment and patient preferences.

A continuous glucose monitor (CGM) is a wearable device that tracks blood glucose (sugar) throughout the day and night. A CGM includes a small disposable sensor that is worn under the skin (often on the stomach or arm). The sensor tests sugar levels every few minutes and sends this information to an attached transmitter and, usually, to a separate receiving device, such as a smart phone. This is a ‘standalone’ CGM. CGM can also be paired with an insulin pump, and this is called an ‘integrated’ CGM.

CGM sensors are composed of three main elements: (i) a needle-based sensor, which is usually inserted in the subcutaneous tissue of the upper arm, abdomen and measures an electrical signal proportional to the glucose concentration present in the interstitial fluid; (ii) a transmitter, which is applied over the sensor and is aimed at transmitting the signal; and (iii) a portable device, which receives the signal and visualizes it on a monitor.

For additional information please refer to: https://www.diabetes.ca/diabetescanadawebsite/media/managing-my-diabetes/tools%20and%20resources/continuous_glucose_monitoring_advocacy_pkg_4.pdf?ext=.pdf